Search in:

Clinical Pharmacology: Advances and Applications Volume 4, 2012 - Issue

Submit an article Journal homepage

Open access

Views

CrossRef citations to date

Altmetric

Original Research

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

Rolf P Kreutz1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA;2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Perry Nystrom2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Yvonne Kreutz2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USACorrespondence[email protected]

Jia Miao2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Zeruesenay Desta2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Jeffrey A Breall1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA

Lang Li2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

ChienWei Chiang2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Richard Kovacs1 Krannert Institute of Cardiology, Indiana University School of Medicine, Indianapolis, IN, USA

David A Flockhart2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

Yan Jin2 Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN, USA

show all

Pages 13-20 | Published online: 20 Feb 2012

Cite this article

Full Article
Figures & data
References
Citations
Metrics
Licensing
Reprints & Permissions
View PDF PDF

References

AngiolilloDJFernandez-OrtizABernardoEVariability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectivesJ Am Coll Cardiol200749141505151617418288
PubMed Web of Science ®Google Scholar
GurbelPABlidenKPGuyerKPlatelet reactivity in patients and recurrent events post-stenting: results of the PREPARE POST-STENTING studyJ Am Coll Cardiol200546101820182616286165
PubMed Web of Science ®Google Scholar
BuonamiciPMarcucciRMiglioriniAImpact of platelet reactivity after clopidogrel administration on drug-eluting stent thrombosisJ Am Coll Cardiol200749242312231717572245
PubMed Web of Science ®Google Scholar
BreetNJvan WerkumJWBoumanHJComparison of platelet function tests in predicting clinical outcome in patients undergoing coronary stent implantationJAMA2010303875476220179285
PubMed Web of Science ®Google Scholar
TrenkDHochholzerWFrommMFCytochrome P450 2C19 681G>A polymorphism and high on-clopidogrel platelet reactivity associated with adverse 1-year clinical outcome of elective percutaneous coronary intervention with drug-eluting or bare-metal stentsJ Am Coll Cardiol200851201925193418482659
PubMed Web of Science ®Google Scholar
MegaJLCloseSLWiviottSDCytochrome P-450 polymorphisms and response to clopidogrelN Engl J Med2009360435436219106084
PubMed Web of Science ®Google Scholar
ColletJPHulotJSPenaACytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort studyLancet2009373966030931719108880
PubMed Web of Science ®Google Scholar
SimonTVerstuyftCMary-KrauseMGenetic determinants of response to clopidogrel and cardiovascular eventsN Engl J Med2009360436337519106083
PubMed Web of Science ®Google Scholar
MegaJLSimonTColletJPReduced-function CYP2C19 genotype and risk of adverse clinical outcomes among patients treated with clopidogrel predominantly for PCI: a meta-analysisJAMA2010304161821183020978260
PubMed Web of Science ®Google Scholar
BoumanHJSchömigEvan WerkumJWParaoxonase-1 is a major determinant of clopidogrel efficacyNat Med201117111011621170047
PubMed Web of Science ®Google Scholar
ShuldinerARO’ConnellJRBlidenKPAssociation of cytochrome P450 2C19 genotype with the antiplatelet effect and clinical efficacy of clopidogrel therapyJAMA2009302884985719706858
PubMed Web of Science ®Google Scholar
KreutzRPTantryUSBlidenKPGurbelPAInflammatory changes during the ‘common cold’ are associated with platelet activation and increased reactivity of platelets to agonistsBlood Coagul Fibrinolysis200718871371817982310
PubMed Web of Science ®Google Scholar
KreutzRPAllooshMMansourKMorbid obesity and metabolic syndrome in Ossabaw miniature swine are associated with increased platelet reactivityDiabetes Metab Syndr Obes201149910521660293
PubMedGoogle Scholar
JakubowskiJAPayneCDLiYGThe use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administrationThromb Haemost200899240941518278193
PubMed Web of Science ®Google Scholar
International HapMap Project [database] Available from: http://www.hapmap.orgAccessed September 26, 2011
Google Scholar
SibbingDKochWMassbergSNo association of paraoxonase- 1 Q192R genotypes with platelet response to clopidogrel and risk of stent thrombosis after coronary stentingEur Heart J201132131605161321527445
PubMed Web of Science ®Google Scholar
LewisJPFischASRyanKParaoxonase 1 (PON1) gene variants are not associated with clopidogrel responseClin Pharmacol Ther201190456857421881565
PubMed Web of Science ®Google Scholar
RidegOKomócsiAMagyarlakiTImpact of genetic variants on post-clopidogrel platelet reactivity in patients after elective percutaneous coronary interventionPharmacogenomics20111291269128021806387
PubMed Web of Science ®Google Scholar
FontanaPJamesRBarazerIRelationship between paraoxonase- 1 activity, its Q192R genetic variant and clopidogrel responsiveness in the ADRIE studyJ Thromb Haemost2011981664166621692977
PubMed Web of Science ®Google Scholar
TrenkDHochholzerWFrommMFParaoxonase-1 Q192R polymorphism and antiplatelet effects of clopidogrel in patients undergoing elective coronary stent placementCirc Cardiovasc Genet20114442943621685174
PubMed Web of Science ®Google Scholar
SimonTStegPGBecquemontLEffect of paraoxonase-1 polymorphism on clinical outcomes in patients treated with clopidogrel after an acute myocardial infarctionClin Pharmacol Ther201190456156721918510
PubMed Web of Science ®Google Scholar
GeislerTSchaeffelerEDipponJCYP2C19 and nongenetic factors predict poor responsiveness to clopidogrel loading dose after coronary stent implantationPharmacogenomics2008991251125918781853
PubMed Web of Science ®Google Scholar
UmemuraKFurutaTKondoKThe common gene variants of CYP2C19 affect pharmacokinetics and pharmacodynamics in an active metabolite of clopidogrel in healthy subjectsJ Thromb Haemost2008681439144118532997
PubMed Web of Science ®Google Scholar

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.

People also read
Recommended articles
Cited by

To cite this article:

Reference style: APA Chicago Harvard

Citation copied to clipboard

Reference styles above use APA (6th edition), Chicago (16th edition) & Harvard (10th edition)

Download citation

Download a citation file in RIS format that can be imported by citation management software including EndNote, ProCite, RefWorks and Reference Manager.

Choose format: RIS BibTex RefWorks Direct Export

Choose options: Citation Citation & abstract Citation & references

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

References

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

Influence of paraoxonase-1 Q192R and cytochrome P450 2C19 polymorphisms on clopidogrel response

References

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date